Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline.

Mild cognitive impairment Neuropsychiatric symptoms Non-pharmacological interventions Physical and cognitive training Quality of life

Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
May 2021
Historique:
received: 28 05 2019
accepted: 17 07 2019
pubmed: 7 8 2019
medline: 1 5 2021
entrez: 7 8 2019
Statut: ppublish

Résumé

Cognitive impairments associated with aging and dementia are major sources of neuropsychiatric symptoms (NPs) and deterioration in quality of life (QoL). Preventive measures to both reduce disease and improve QoL in those affected are increasingly targeting individuals with mild cognitive impairment (MCI) at early disease stage. However, NPs and QoL outcomes are too commonly overlooked in intervention trials. The purpose of this study was to test the effects of physical and cognitive training on NPs and QoL in MCI. Baseline data from an MCI court (N = 93, mean age 74.9 ± 4.7) enrolled in the Train the Brain (TtB) study were collected. Subjects were randomized in two groups: a group participated to a cognitive and physical training program, while the other sticked to usual standard care. Both groups underwent a follow-up re-evaluation after 7 months from baseline. NPs were assessed using the Neuropsychiatric Inventory (NPI) and QoL was assessed using Quality of Life-Alzheimer's Disease (QOL-AD) scale. After 7 months of training, training group exhibited a significant reduction of NPs and a significant increase in QOL-AD with respect to no-training group (p = 0.0155, p = 0.0013, respectively). Our preliminary results suggest that a combined training can reduce NPs and improve QoL. Measuring QoL outcomes is a potentially important factor in ensuring that a person with cognitive deficits can 'live well' with pathology. Future data from non-pharmacological interventions, with a larger sample and a longer follow-up period, could confirm the results and the possible implications for such prevention strategies for early cognitive decline.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Cognitive impairments associated with aging and dementia are major sources of neuropsychiatric symptoms (NPs) and deterioration in quality of life (QoL). Preventive measures to both reduce disease and improve QoL in those affected are increasingly targeting individuals with mild cognitive impairment (MCI) at early disease stage. However, NPs and QoL outcomes are too commonly overlooked in intervention trials. The purpose of this study was to test the effects of physical and cognitive training on NPs and QoL in MCI.
METHODS METHODS
Baseline data from an MCI court (N = 93, mean age 74.9 ± 4.7) enrolled in the Train the Brain (TtB) study were collected. Subjects were randomized in two groups: a group participated to a cognitive and physical training program, while the other sticked to usual standard care. Both groups underwent a follow-up re-evaluation after 7 months from baseline. NPs were assessed using the Neuropsychiatric Inventory (NPI) and QoL was assessed using Quality of Life-Alzheimer's Disease (QOL-AD) scale.
RESULTS RESULTS
After 7 months of training, training group exhibited a significant reduction of NPs and a significant increase in QOL-AD with respect to no-training group (p = 0.0155, p = 0.0013, respectively). Our preliminary results suggest that a combined training can reduce NPs and improve QoL.
CONCLUSIONS CONCLUSIONS
Measuring QoL outcomes is a potentially important factor in ensuring that a person with cognitive deficits can 'live well' with pathology. Future data from non-pharmacological interventions, with a larger sample and a longer follow-up period, could confirm the results and the possible implications for such prevention strategies for early cognitive decline.

Identifiants

pubmed: 31385203
doi: 10.1007/s40520-019-01280-w
pii: 10.1007/s40520-019-01280-w
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1249-1257

Subventions

Organisme : Fondazione Pisa
ID : Train the Brain

Investigateurs

L Maffei (L)
E Picano (E)
M G Andreassi (MG)
A Angelucci (A)
F Baldacci (F)
L Baroncelli (L)
T Begenisic (T)
P F Bellinvia (PF)
N Berardi (N)
L Biagi (L)
J Bonaccorsi (J)
E Bonanni (E)
U Bonuccelli (U)
A Borghini (A)
C Braschi (C)
M Broccardi (M)
R M Bruno (RM)
M Caleo (M)
C Carlesi (C)
L Carnicelli (L)
G Cartoni (G)
L Cecchetti (L)
M C Cenni (MC)
R Ceravolo (R)
L Chico (L)
S Cintoli (S)
G Cioni (G)
M Coscia (M)
M Costa (M)
G D'Angelo (G)
P D'Ascanio (P)
M De Nes (M)
S Del Turco (S)
E Di Coscio (E)
M Di Galante (M)
N di Lascio (N)
F Faita (F)
I Falorni (I)
U Faraguna (U)
A Fenu (A)
L Fortunato (L)
R Franco (R)
L Gargani (L)
R Gargiulo (R)
L Ghiadoni (L)
F S Giorgi (FS)
R Iannarella (R)
C Iofrida (C)
C Kusmic (C)
F Limongi (F)
M Maestri (M)
M Maffei (M)
S Maggi (S)
M Mainardi (M)
L Mammana (L)
A Marabotti (A)
V Mariotti (V)
E Melissari (E)
A Mercuri (A)
S Micera (S)
S Molinaro (S)
R Narducci (R)
T Navarra (T)
M Noale (M)
C Pagni (C)
S Palumbo (S)
R Pasquariello (R)
S Pellegrini (S)
P Pietrini (P)
T Pizzorusso (T)
A Poli (A)
L Pratali (L)
A Retico (A)
E Ricciardi (E)
G Rota (G)
A Sale (A)
S Sbrana (S)
G Scabia (G)
M Scali (M)
D Scelfo (D)
R Sicari (R)
G Siciliano (G)
F Stea (F)
S Taddei (S)
G Tognoni (G)
A Tonacci (A)
M Tosetti (M)
S Turchi (S)
L Volpi (L)

Références

Mariani E, Monastero R, Mecocci P (2007) Mild cognitive impairment: a systematic review. J Alzheimers Dis 12:23–35. https://doi.org/10.3233/JAD-2007-12104
doi: 10.3233/JAD-2007-12104 pubmed: 17851192
Petersen RC, Smith GE, Waring SC et al (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308. https://doi.org/10.1001/archneur.56.3.303
doi: 10.1001/archneur.56.3.303 pubmed: 10190820
Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183–194. https://doi.org/10.1111/j.1365-2796.2004.01388
doi: 10.1111/j.1365-2796.2004.01388 pubmed: 15324362
Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279. https://doi.org/10.1016/j.jalz.2011.03.008
doi: 10.1016/j.jalz.2011.03.008 pubmed: 21514249 pmcid: 3312027
Palmer K, Backman L, Winblad B et al (2008) Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am J Geriatr Psychiatry 16:603–611. https://doi.org/10.1097/JGP.0b013e3181753a64
doi: 10.1097/JGP.0b013e3181753a64 pubmed: 18591580
Sperling R, Johnson K (2013) Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria. Continuum (Minneap Minn) 19:325–338. https://doi.org/10.1212/01.CON.0000429181.60095.99
doi: 10.1212/01.CON.0000429181.60095.99
Sperling R, Mormino E, Johnson K (2014) Evolution of preclinical Alzheimer’s disease: implications for prevention trials. Neuron 84:608–622. https://doi.org/10.1016/j.neuron.2014.10.038
doi: 10.1016/j.neuron.2014.10.038 pubmed: 25442939 pmcid: 4285623
Bruscoli M, Lovestone S (2004) Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr 16:129–140. https://doi.org/10.1017/S1041610204000092
doi: 10.1017/S1041610204000092 pubmed: 15318760
Manly JJ, Tang MX, Schupf N et al (2008) Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 63:494–506. https://doi.org/10.1002/ana.21326
doi: 10.1002/ana.21326 pubmed: 18300306 pmcid: 2375143
Koepsell TD, Monsell SE (2012) Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology 79:1591–1598. https://doi.org/10.1212/WNL.0b013e31826e26b7
doi: 10.1212/WNL.0b013e31826e26b7 pubmed: 23019264 pmcid: 3475624
Apostolova LG, Cummings JL (2008) Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord 25:115–126. https://doi.org/10.1159/000112509
doi: 10.1159/000112509 pubmed: 18087152
Perneczky R, Pohl C, Sorg C et al (2006) Impairment of activities of daily living requiring memory or complex reasoning as part of the MCI syndrome. Int J Geriatr Psychiatry 21:158–162. https://doi.org/10.1002/gps.1444
doi: 10.1002/gps.1444 pubmed: 16416470
Jefferson AL, Byerly LK, Vanderhill S et al (2008) Characterization of activities of daily living in individuals with mild cognitive impairment. Am J Geriatr Psychiatry 16:375–383. https://doi.org/10.1097/JGP.0b013e318162f197
doi: 10.1097/JGP.0b013e318162f197 pubmed: 18332397 pmcid: 2682324
Teng E, Becker BW, Woo E et al (2010) Subtle deficits in instrumental activities of daily living in subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord 30:189–197. https://doi.org/10.1159/000313540
doi: 10.1159/000313540 pubmed: 20798539 pmcid: 2948658
Monastero R, Mangialasche F, Camarda C et al (2009) A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis 18:11–30. https://doi.org/10.3233/JAD-2009-1120
doi: 10.3233/JAD-2009-1120 pubmed: 19542627
Winblad B, Palmer K, Kivipelto M et al (2004) Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on mild cognitive impairment. J Intern Med 256:240–246. https://doi.org/10.1111/j.1365-2796.2004.01380
doi: 10.1111/j.1365-2796.2004.01380 pubmed: 15324367
Kameyama K, Tsutou A, Fujino H (2016) The relationship between health-related quality of life and higher-level functional capacity in elderly women with mild cognitive impairment. J Phys Ther Sci 28:1312–1317. https://doi.org/10.1589/jpts.28.1312
doi: 10.1589/jpts.28.1312 pubmed: 27190474 pmcid: 4868234
Teng E, Tassniyom K, Lu PH (2012) Reduced quality of life ratings in mild cognitive impairment: analyses of subject and informant responses. Am J Geriatr Psychiatry 20:1016–1025. https://doi.org/10.1097/JGP.0b013e31826ce640
doi: 10.1097/JGP.0b013e31826ce640 pubmed: 23018474 pmcid: 3513348
Scholzel-Dorenbos CJ, van der Steen MJ, Engels LK et al (2007) Assessment of quality of life as outcome in dementia and MCI intervention trials: a systematic review. Alzheimer Dis Assoc Disord 21:172–178. https://doi.org/10.1097/WAD.0b013e318047df4c
doi: 10.1097/WAD.0b013e318047df4c pubmed: 17545745
St John P, Montgomery PR (2010) Cognitive impairment and life satisfaction in older adults. Int J Geriatr Psychiatry 25:814–821. https://doi.org/10.1002/gps.2422
doi: 10.1002/gps.2422 pubmed: 20623664
Bowling A, Rowe G, Adams S et al (2015) Quality of life in dementia: a systematically conducted narrative review of dementia-specific measurement scales. Aging Ment Health 19:13–31. https://doi.org/10.1080/13607863.2014.915923
doi: 10.1080/13607863.2014.915923 pubmed: 24881888
Moniz-Cook E, Vernooij-Dassen M, Woods R et al (2008) A European consensus on outcome measures for psychosocial intervention research in dementia care. Aging Ment Health 12:14–29. https://doi.org/10.1080/13607860801919850
doi: 10.1080/13607860801919850 pubmed: 18297476
Logsdon RG, Gibbons LE, McCurry SM et al (1999) Quality of life in Alzheimer’s disease: patient and caregiver reports. J Ment Health Aging 5:21–32
Sale A, Berardi N, Maffei L (2014) Environment and brain plasticity: towards an endogenous pharmacotherapy. Physiol Rev 94:189–234. https://doi.org/10.1152/physrev.00036.2012
doi: 10.1152/physrev.00036.2012 pubmed: 24382886
Huckans M, Hutson L, Twamley E et al (2013) Efficacy of cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interventions. Neuropsychol Rev 23:63–80. https://doi.org/10.1007/s11065-013-9230-9
doi: 10.1007/s11065-013-9230-9 pubmed: 23471631 pmcid: 3640648
Logsdon RG, Gibbons LE, McCurry SM et al (2002) Assessing quality of life in older adults with cognitive impairment. Psychosom Med 64:510–519. https://doi.org/10.1097/00006842-200205000-00016
doi: 10.1097/00006842-200205000-00016 pubmed: 12021425
Train the Brain Consortium (2017) Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study. Sci Rep 7:39471. https://doi.org/10.1038/srep39471
doi: 10.1038/srep39471
Cummings JL, Mega M, Gray K et al (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314. https://doi.org/10.1212/WNL.44.12.2308
doi: 10.1212/WNL.44.12.2308 pubmed: 7991117
Gates NJ, Sachdev P (2014) Is cognitive training an effective treatment for preclinical and early Alzheimer’s disease? J Alzheimers Dis 42:S551–S559. https://doi.org/10.1007/s11065-017-9363-3
doi: 10.1007/s11065-017-9363-3 pubmed: 25171716
Morris SB (2008) Estimating effect sizes from pretest-posttest-control group designs. Organ Res Methods 11:365–386. https://doi.org/10.1177/1094428106291059
doi: 10.1177/1094428106291059
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198. https://doi.org/10.1016/0022-3956(75)90026-6
doi: 10.1016/0022-3956(75)90026-6 pubmed: 1202204
Selbæk G, Engedal K (2012) Stability of the factor structure of the neuropsychiatric inventory in a 31-month follow-up study of a large sample of nursing-home patients with dementia. Int Psychogeriatr 24:62–73. https://doi.org/10.1017/S104161021100086X
doi: 10.1017/S104161021100086X pubmed: 21682940
Apostolova LG, Di LJ, Duffy EL et al (2014) Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer’s disease. Dement Geriatr Cogn Disord 37:315–326. https://doi.org/10.1159/000351009
doi: 10.1159/000351009 pubmed: 24481207 pmcid: 4057985
Donovan NJ, Amariglio RE, Zoller AS et al (2014) Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry 22:1642–1651. https://doi.org/10.1016/j.jagp.2014.02.007
doi: 10.1016/j.jagp.2014.02.007 pubmed: 24698445 pmcid: 4145054
Missotten P, Squelard G, Ylieff M et al (2008) Relationship between quality of life and cognitive decline in dementia. Dement Geriatr Cogn Disord 25:564–572. https://doi.org/10.1159/000137689
doi: 10.1159/000137689 pubmed: 18544978
Ryan KA, Weldon A, Persad C et al (2012) Neuropsychiatric symptoms and executive functioning in patients with mild cognitive impairment: relationship to caregiver burden. Dement Geriatr Cogn Disord 34:206–215. https://doi.org/10.1159/000339955
doi: 10.1159/000339955 pubmed: 23128102 pmcid: 3698846
Sheikh F, Ismail Z, Mortby ME et al (2017) Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden. Int Psychogeriatr 7:1–12. https://doi.org/10.1017/S104161021700151X
doi: 10.1017/S104161021700151X
Isik AT, Soysal P, Solmi M et al (2018) Bidirectional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer’s disease: a narrative review. Int J Geriatr Psychiatry. https://doi.org/10.1002/gps.4965
doi: 10.1002/gps.4965 pubmed: 30198597
Buschert VC, Friese U, Teipel SJ et al (2011) Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer’s disease: a pilot study. J Alzheimers Dis 25:679–694. https://doi.org/10.3233/JAD-2011-100999
doi: 10.3233/JAD-2011-100999 pubmed: 21483095
Jean L, Bergeron ME, Thivierge S et al (2010) Cognitive intervention programs for individuals with mild cognitive impairment: systematic review of the literature. Am J Geriatr Psychiatry 18:281–296. https://doi.org/10.1097/JGP.0b013e3181c37ce9
doi: 10.1097/JGP.0b013e3181c37ce9 pubmed: 20220584
Young SN (2007) How to increase serotonin in the human brain without drugs. J Psychiatry Neurosci 32:394–399
pubmed: 18043762 pmcid: 2077351
Veronese N, Solmi M, Basso C et al (2018) Role of physical activity in ameliorating neuropsychiatric symptoms in Alzheimer disease: a narrative review. Int J Geriatr Psychiatry. https://doi.org/10.1002/gps.4962
doi: 10.1002/gps.4962 pubmed: 30198597
Brookmeyer R, Johnson E, Ziegler-Graham K et al (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3:186–191. https://doi.org/10.1016/j.jalz.2007.04.381
doi: 10.1016/j.jalz.2007.04.381 pubmed: 19595937
Liu S, Jones RN, Glymour MM (2010) Implications of lifecourse epidemiology for research on determinants of adult disease. Public Health Rev 32:489–511. https://doi.org/10.1007/BF03391613
doi: 10.1007/BF03391613 pubmed: 24639598 pmcid: 3955391
Dyer SM, Harrison SL, Laver K et al (2018) An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int Psychogeriatr 30:295–309. https://doi.org/10.1017/S1041610217002344
doi: 10.1017/S1041610217002344 pubmed: 29143695
Ngandu T, Lehtisalo J, Solomon A et al (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385:2255–2263. https://doi.org/10.1016/S0140-6736(15)60461-5
doi: 10.1016/S0140-6736(15)60461-5 pubmed: 25771249

Auteurs

Simona Cintoli (S)

Institute of Neuroscience of the CNR, Via G. Moruzzi 1, 56100, Pisa, Italy.
Department NEUROFARBA, University of Florence, Florence, Italy.

Claudia Radicchi (C)

Institute of Neuroscience of the CNR, Via G. Moruzzi 1, 56100, Pisa, Italy.

Marianna Noale (M)

Institute of Neuroscience of the CNR, Via G. Moruzzi 1, 56100, Pisa, Italy.

Stefania Maggi (S)

Institute of Neuroscience of the CNR, Via G. Moruzzi 1, 56100, Pisa, Italy.

Giuseppe Meucci (G)

Department of Clinical Medicine, U.O.C. Neurology, Livorno, Italy.

Gloria Tognoni (G)

Department of Clinical and Experimental Medicine-Neurology Unit, University of Pisa and AOU Pisa, Pisa, Italy.

Ubaldo Bonuccelli (U)

Department of Clinical and Experimental Medicine-Neurology Unit, University of Pisa and AOU Pisa, Pisa, Italy.

Alessandro Sale (A)

Institute of Neuroscience of the CNR, Via G. Moruzzi 1, 56100, Pisa, Italy.

Nicoletta Berardi (N)

Institute of Neuroscience of the CNR, Via G. Moruzzi 1, 56100, Pisa, Italy. berardi@in.cnr.it.

Lamberto Maffei (L)

Institute of Neuroscience of the CNR, Via G. Moruzzi 1, 56100, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH